StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amgen (AMGN) PT Raised to $210 at Piper Jaffray Following 2Q
July 27, 2018 6:45 AM
Piper Jaffray raised its price target on Amgen (NASDAQ: AMGN) to $210.00 (from $190.00) while maintaining a Overweight rating following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Amgen (AMGN) PT Raised to $179 at Baird
July 27, 2018 8:48 AM
Amgen (AMGN) PT Raised to $205 at Cowen Following 'Beat and Raise'
July 27, 2018 8:24 AM
Amgen (AMGN) PT Raised to $194 at UBS
July 27, 2018 7:00 AM
Amgen (AMGN) PT Raised to $195 at Barclays
July 27, 2018 6:56 AM
Options expected to be active: EA EXPE AMGN TLT
July 27, 2018 5:17 AM
Amgen profit beats Street view, will not raise prices again in 2018
July 26, 2018 4:16 PM
Amgen (AMGN) Tops Q2 EPS by 29c
July 26, 2018 4:02 PM
Amgen Announces Succession Plans For Two Executive Officers
July 26, 2018 4:02 PM
Amgen Reports Second Quarter 2018 Financial Results
July 26, 2018 4:01 PM
Amgen (AMGN) call put ratio 1.42 calls to 1 put into EPS and outlook
July 26, 2018 2:29 PM
Amgen (AMGN) weekly option implied volatility increases into EPS and outlook
July 26, 2018 5:19 AM
Amgen (AMGN) call put ratio 1 to 1 into Q2 and outlook
July 25, 2018 10:37 AM
Amgen (AMGN) weekly option implied volatility elevated into EPS and outlook
July 25, 2018 5:27 AM
_58cbc46cd3c33.jpg)
